CLINICAL TRIALS PROFILE FOR CLOZARIL
✉ Email this page to a colleague
All Clinical Trials for CLOZARIL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00042224 ↗ | Electroconvulsive Therapy in Clozapine Refractory Schizophrenia | Completed | National Institute of Mental Health (NIMH) | Phase 1/Phase 2 | 2000-12-01 | This study will evaluate electroconvulsive therapy (ECT) in patients who have not responded adequately to clozapine. |
NCT00042224 ↗ | Electroconvulsive Therapy in Clozapine Refractory Schizophrenia | Completed | Northwell Health | Phase 1/Phase 2 | 2000-12-01 | This study will evaluate electroconvulsive therapy (ECT) in patients who have not responded adequately to clozapine. |
NCT00154258 ↗ | A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia | Completed | Novartis | Phase 2 | 2001-04-01 | Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia. |
NCT00169091 ↗ | Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia | Terminated | Commonwealth Research Center, Massachusetts | Phase 4 | 1996-03-01 | This study will examine the physical responses brought on by clozapine and haloperidol in people experiencing their first episode of schizophrenia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CLOZARIL
Condition Name
Clinical Trial Locations for CLOZARIL
Trials by Country
Clinical Trial Progress for CLOZARIL
Clinical Trial Phase
Clinical Trial Sponsors for CLOZARIL
Sponsor Name